In BC tumorigenesis and progression, abnormal expression of H19 is governed by a number of molecular mechanisms, including microRNA-675 encoding, competing with endogenous RNA regulation, and interacting with Myc [235, 236]. The gene discussed is H19; the disease is breast cancer.